Regulatory Open Forum

 View Only
Expand all | Collapse all

Antimicrobial Effectiveness

  • 1.  Antimicrobial Effectiveness

    Posted 10-Feb-2020 16:57

    Is there an FDA guidance document on antimicrobial effectiveness testing? I am looking for guidance on testing required for the use of Sulfadiazine with a  hydrogel wound dressing.  


  • 2.  RE: Antimicrobial Effectiveness

    Posted 11-Feb-2020 02:30
    Hi Ann,

    I am not exactly sure of your goal with that testing.
    If you want to check sulfadiazine as a preservative of your formulation, USP <51>, Antimicrobial Effectiveness Test is the methodology of choice. This is very common in pharmaceutical preparations and FDA has a lot of guidelines.
    If you want to check that your device has antimicrobial properties, there are various standards depending on the application, such as ASTM E-2149, ASTM E-2315 or other tests for biocides such as EN 1040, EN 1276 etc.
    FDA had released in the past (2007) a guideline regarding the antimicrobial agents in medical devices, but it was withdrawn in 2015.

    Hope that helps

    ------------------------------
    Spyros Drivelos
    Medical Devices Expert, RAC
    Agia Paraskevi, Athens
    Greece
    ------------------------------



  • 3.  RE: Antimicrobial Effectiveness

    Posted 11-Feb-2020 08:47
    Thanks!
    Ann E Kemp
    Regulatory and Quality Services, LLC
    1635 Juno Ave
    St Paul, MN 55116
    612-730-0217







  • 4.  RE: Antimicrobial Effectiveness

    Posted 11-Feb-2020 09:01
    Hi Ann

    Just a comment.. There are those bench tests yes, but clinicals may be required for your dressing, depending on the indications and claims you want to make.  (My experience speaking here from work on Tegaderm CHG, a hydrogel dressing with chlorhexidine gluconate).   It will be considered a combo product, but you know this I am sure.

    Assuming you.might consider a pre-sub to flesh out pre-clinical, biocomp, stability, bench, and any clinical study requirements..

    PM if you'd like. Best of luck!






    ------------------------------
    Ginger Cantor, MBA, RAC
    Founder/Principal Consultant
    Centaur Consulting LLC
    River Falls, Wisconsin 54022 USA
    715-307-1850
    centaurconsultingllc@gmail.com
    ------------------------------



  • 5.  RE: Antimicrobial Effectiveness

    Posted 11-Feb-2020 09:04
    Thanks so much!
    Ann E Kemp
    Regulatory and Quality Services, LLC
    1635 Juno Ave
    St Paul, MN 55116
    612-730-0217







  • 6.  RE: Antimicrobial Effectiveness

    Posted 12-Feb-2020 07:28
    All,

    I agree with Ginger's comments.  Depending on your indication (and marketing claims), FDA will likely expect in vivo as well as in vitro testing, and against clinical isolates as opposed to ATCC cultures.  They are very keen on real world evidence before allowing a wide ranging antimicrobial claim.  A pre-sub is the best route to guide your regulatory and testing strategy.

    James

    ------------------------------
    James Bonds J.D.
    Director Regulatory Affairs
    Atlanta GA
    United States
    ------------------------------



  • 7.  RE: Antimicrobial Effectiveness

    Posted 11-Feb-2020 11:01
    Ann,

    There isn't a FDA Guidance for Industry on antimicrobial (AM) effectiveness nor is there a recognized standard.  However, we have used USP <51> to support preservative effectiveness claims.  Additionally, you may want to refer to the Sep 2016 panel meeting in which FDA discusses antimicrobial claims, i.e. in the meeting FDA discusses hard dressings which can have certain AM claims while amorphous gels can have other very limited claims.  In my experience, a comparison to the predicate device is no longer the litmus test for what is allowed.  Older products can and do have better claims than more recent products...just my 2 cents.

    Respectfully,

    ------------------------------
    William Coulston PMP, MS, RAC
    Quality & Regulatory Manager
    San Antonio TX
    United States
    ------------------------------



  • 8.  RE: Antimicrobial Effectiveness

    Posted 11-Feb-2020 12:12
    Yes, I did see the panel meeting information from 2016.
    This product is a powder that forms a gel when applied to a wound. The powder absorbs exudate (saline is added also) and forms a gel covering. The silver would be used for antimicrobial purposes. 
    Also I am struggling to find a predicate. Most of what I see are gels, creams or solid wound dressings with silver. 
    Ann E Kemp
    Regulatory and Quality Services, LLC
    1635 Juno Ave
    St Paul, MN 55116
    612-730-0217





  • 9.  RE: Antimicrobial Effectiveness

    Posted 11-Feb-2020 12:03
    Hi Ann.

    Just to piggy-back onto Spyros's comment - if this is about the effectiveness of sulfadiazine as a preservative of your gel, you need to also account for the following:

    1. If the sulfadiazine is embedded in the gel, it is unlikely to fully prevent contamination in general because it is not going to be able to get at the organisms of interest.
    2. If this is for use as a preservative, you need to ensure that the gel (when tested) is loose enough to routinely do several things:
      A. it is malleable enough to allow the material to be mixed with the organisms of interest
      B. It remains malleable enough to be sampled at each of the time points.
      C. The organisms being tested can be removed from the material aseptically in order to allow for enumeration.​

    ------------------------------
    Victor Mencarelli
    Director Regulatory Affairs
    United States
    ------------------------------



  • 10.  RE: Antimicrobial Effectiveness

    Posted 11-Feb-2020 12:26
    I'm not aware of any FDA guidance specific to AET, but you may find FDA's Guidance for Industry Chronic Cutaneous Ulcer and Burn Wounds - Developing Products for Treatment helpful.  There's a section on WOUND-TREATMENT PRODUCT QUALITY MICROBIOLOGY.  I would also refer you to USP <51> ANTIMICROBIAL EFFECTIVENESS TESTING.

    ------------------------------
    Tom
    Senior Director, Regulatory Affairs CMC
    Chicago
    ------------------------------



  • 11.  RE: Antimicrobial Effectiveness

    Posted 12-Feb-2020 09:09
    As mentioned above take a look at the 2016 FRO panel meeting presentation.

    ------------------------------
    Josh Crist
    Senior Consultant
    Ellicott City MD
    United States
    ------------------------------



  • 12.  RE: Antimicrobial Effectiveness

    Posted 12-Feb-2020 09:25
    Ann,
    Your testing should use species that your device is intended to inhibit. We do a fair amount of these type of submissions and we typically create a testing plan with justified species (depending on where the device is used on the body) and submit this proposal to FDA in a presub.
    Hope that helps,

    ------------------------------
    Linda Braddon
    CEO
    Woodstock GA
    United States
    ------------------------------



  • 13.  RE: Antimicrobial Effectiveness

    Posted 12-Feb-2020 09:31
    Thanks everyone for the advice. Much appreciated. 

    Ann

    ------------------------------
    Ann Kemp RAC, CQA
    Consultant
    Saint Paul MN
    United States
    ------------------------------